Dr. John Waples, M.D.
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Alabama School of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,925
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: University of Alabama School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
AL license 00021807
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Huntsville Hospital Huntsville, AL
- Crestwood Medical Center Huntsville, AL
- Marshall Medical Centers Boaz, AL
- Decatur Morgan Hospital - Decatur Campus Decatur, AL
- Athens Limestone Hospital Athens, AL
Medical groups
- Oncology Specialties, P.c. (109 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,925
- Services billed
- 608,879
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, levoleucovorin (khapzory), 0.5 mg | 103,750 | 22 |
| Injection, pembrolizumab, 1 mg | 56,800 | 49 |
| Injection, nivolumab, 1 mg | 55,600 | 21 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 51,150 | 45 |
| Injection, denosumab, 1 mg | 46,680 | 259 |
| Injection, paclitaxel protein-bound particles, 1 mg | 19,200 | 13 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 17,280 | 16 |
| Injection, aprepitant, 1 mg | 15,730 | 32 |
| Injection, ferric derisomaltose, 10 mg | 15,000 | 132 |
| Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 13,990 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Huntsville, AL | 318 |
| Anastrozole Other prescribers in Huntsville, AL | 318 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Huntsville, AL | 242 |
| Xarelto (rivaroxaban) Other prescribers in Huntsville, AL | 215 |
| Potassium Chloride Other prescribers in Huntsville, AL | 194 |
| Meloxicam Other prescribers in Huntsville, AL | 151 |
| Levothyroxine Sodium Other prescribers in Huntsville, AL | 138 |
| Zolpidem Tartrate Other prescribers in Huntsville, AL | 133 |
| Gabapentin Other prescribers in Huntsville, AL | 128 |
| Omeprazole Other prescribers in Huntsville, AL | 116 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 33 companies reported 74 payments worth $8,482 in total to this clinician.
| Kyowa Kirin, Inc. | $3,900 |
|---|---|
| Pfizer Inc. | $1,474 |
| Genzyme Corporation | $408 |
| GlaxoSmithKline, LLC. | $292 |
| Blueprint Medicines Corporation | $218 |
| Geron Corporation | $195 |
| Jazz Pharmaceuticals Inc. | $166 |
| AstraZeneca Pharmaceuticals LP | $162 |
| Consulting Fee | $5,200 |
|---|---|
| Food and Beverage | $3,262 |
| Education | $20.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Kyowa Kirin, Inc. Dec 18, 2025 | Consulting Fee POTELIGEO · MONOCLONAL ANTIBODY | $3,900 |
| Pfizer Inc. Nov 12, 2025 | Consulting Fee IBRANCE · ONCOLOGY | $1,300 |
| Aveo Pharmaceuticals, Inc. Apr 29, 2025 | Education FOTIVDA · Oncology · in-kind | $20.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.